Cargando…
A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: Time to dispense with the hemoglobin A1C in end-stage kidney disease
Chronic kidney disease remains as one of the major complications for individuals with diabetes and contributes to considerable morbidity. Individuals subjected to dialysis therapy, half of whom are diabetic, experience a mortality of ∼20% per year. Understanding factors related to mortality remains...
Autor principal: | Freedman, Barry I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379614/ https://www.ncbi.nlm.nih.gov/pubmed/22723586 http://dx.doi.org/10.2337/dc12-0027 |
Ejemplares similares
-
A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: A1C remains the gold standard outcome predictor in diabetic dialysis patients
por: Kalantar-Zadeh, Kamyar
Publicado: (2012) -
A Critical Analysis of the Clinical Use of Incretin-Based Therapies : Are the GLP-1 therapies safe?
por: Butler, Peter C., et al.
Publicado: (2013) -
A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks
por: Nauck, Michael A.
Publicado: (2013) -
Liver Steatosis is a Driving Factor of Inflammation
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022) -
Insulin Analogs—Is There a Compelling Case to Use Them? No!
por: Davidson, Mayer B.
Publicado: (2014)